Baudax Bio, Inc.
BXRXQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $7 | $1 | $0 | $0 |
| - Cash | $5,259 | $15,891 | $30,342 | $17,740 |
| + Debt | $7,119 | $8,531 | $9,778 | $773 |
| Enterprise Value | $1,867 | -$7,359 | -$20,564 | -$16,967 |
| Revenue | $1,269 | $1,080 | $493 | $0 |
| % Growth | 17.5% | 119.1% | – | – |
| Gross Profit | -$5,740 | -$1,365 | -$1,239 | $0 |
| % Margin | -452.3% | -126.4% | -251.3% | – |
| EBITDA | -$33,581 | -$49,560 | -$72,187 | -$32,077 |
| % Margin | -2,646.3% | -4,588.9% | -14,642.4% | – |
| Net Income | -$58,795 | -$19,769 | -$76,100 | -$32,557 |
| % Margin | -4,633.2% | -1,830.5% | -15,436.1% | – |
| EPS Diluted | -177.3 | -361.16 | -5,714.8 | -4,872.07 |
| % Growth | 50.9% | 93.7% | -17.3% | – |
| Operating Cash Flow | -$27,793 | -$49,270 | -$44,058 | -$50,044 |
| Capital Expenditures | -$20 | -$203 | -$639 | -$1,484 |
| Free Cash Flow | -$27,813 | -$49,473 | -$44,697 | -$51,528 |